市場調查報告書

生物外科(生物學的外科治療)的全球市場:成長、趨勢、預測

Biosurgery Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921283
出版日期 內容資訊 英文 113 Pages
商品交期: 2-3個工作天內
價格
生物外科(生物學的外科治療)的全球市場:成長、趨勢、預測 Biosurgery Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 113 Pages
簡介

生物外科(生物學的外科治療)產品,用於修復損傷的組織和骨頭的各種手術。生物外科(生物學的外科治療)開創在外科治療,創傷、組織管理,再生治療中的新範式。還有生物製藥和合成物質的恰當組合找出再生治療新的可能性。全球生物外科(生物學的外科治療)市場在2020年到2025年間,預測將以7.4%的年複合成長率發展。老年人口的增加,及慢性疾病的盛行率上升,手術數量的增加,導致先進性產品的銷售的研究活動的強力的配合措施等,預計促進這個市場成長。

本報告提供全球生物外科(生物學的外科治療)市場調查,市場概要,各產品、用途、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長要素
    • 老年人口的增加
    • 與慢性疾病有關聯的手術的盛行率上升
    • 著重導致新產品及新產品銷售的研究開發
  • 市場阻礙因素
    • 生物外科產品的價格高和外科治療的成本上升
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第5章 市場區隔

  • 各產品
    • 移植骨替代物
    • 軟組織附件
    • 止血劑
    • 外科用密封膠、黏劑
    • 粘著阻隔
    • 其他
  • 各用途
    • 整形外科
    • 一般外科
    • 神經外科
    • 心血管外科
    • 婦產科手術
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Baxter International, Inc.
    • B.Braun Melsungen AG
    • Becton, Dickinson and Company (CR Bard)
    • Johnson & Johnson
    • Medtronic, PLC.
    • MAQUET Holding BV & Co. Kg. (Getinge Group)
    • Cohera Medical Inc.
    • Integra Lifesciences Holdings Corporation
    • Commonwealth Serum Laboratories (CSL)
    • Hemostasis, LLC
    • CryoLife, Inc.

第7章 市場機會及未來趨勢

目錄
Product Code: 67158

Market Overview

The biosurgery market studied was anticipated to grow with a CAGR of 7.4%, during the forecast period. The major factors attributing to the growth of the biosurgery market are increasing geriatric population, rising prevalence of chronic diseases and related surgeries, and a strong focus on R&D leading to the launch of new and advanced products. The global increase in the number of geriatrics population and obese people is likely to lead to numerous health consequences, like greater incidences of ortho and neuro problems. Consequently, the geriatric population and population with obesity are at a higher risk of multiple disorders and diseases. According to the United Nations report in 2017, there were an estimated 962 million people aged 60 or over in the world, comprising 13% of the global population. The population aged 60 or above is growing at a rate of about 3% per year. It was estimated that Europe had the highest percentage of the population aged 60 or over in 2017. Thus, the rise in the geriatric and obese population is acting as a major driver for the growth of the biosurgery market.

Scope of the Report

Biosurgery products are used in various surgeries and repair weakened and damaged tissues and bones. Biosurgery has opened a new paradigm in surgical care, wound and tissue management, and regenerative healing. It has even unlocked new potential in regenerative healing with the right mix of biologics and synthetics.

Key Market Trends

Neurology Segment is Expected to Grow with Good CAGR in the Application Segment

  • Neurology and spine-related surgery applications of biosurgery are the major market segments and their growth is driven by a mainly wide application of bone graft substitute products in different biosurgery processes.
  • Another major application segment of biosurgery is orthopedic surgery. Due to the fact that each year the number of orthopedic cases is increasing primarily due to factors such as the increasing obese and aging population.
  • Even the cardiovascular surgery segment is expected to grow with a positive CAGR in the forecast period, and factors such as the increasing number of cardiac problems in the people across the globe are augmenting the market growth.
  • For instance, according to the data provided by the American Heart Association 2019, Cardiovascular disease (CVD) was listed as the underlying cause of death, which have accounted for approximately 840,678 deaths in the United States in the year 2016, this is approximately 1 of every 3 deaths in the region.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. This is due to the increasing number of surgeries, rising obese patients and increasing geriatric population. In the North America region, the United States holds the largest market share due to factors such as increasing count of geriatrics, along with the growing healthcare industry, which is anticipated to stimulate the demand in this region. Substantial investments by governments to strengthen public healthcare delivery is a key factor augmenting the growth of the market.

Competitive Landscape

The biosurgery market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the prominent players are vigorously making acquisitions with the other companies to consolidate their market positions across the globe. Companies that are currently vying for a greater revenue share in the global biosurgery market are Baxter International Inc., Johnson & Johnson, Becton Dickinson and Company (C.R. Bard), B. Braun Melsungen AG, CryoLife, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Geriatric Population
    • 4.2.2 Rising Prevalence of Chronic Diseases and Related Surgeries
    • 4.2.3 Strong focus on R&D leading to the launch of new and advanced products
  • 4.3 Market Restraints
    • 4.3.1 High price of biosurgery products and rising cost of surgical procedures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Bone-Graft Substitutes
    • 5.1.2 Soft-Tissue Attachments
    • 5.1.3 Hemostatic Agents
    • 5.1.4 Surgical Sealants and Adhesives
    • 5.1.5 Adhesion Barriers
    • 5.1.6 Others
  • 5.2 By Application
    • 5.2.1 Orthopedic Surgery
    • 5.2.2 General Surgery
    • 5.2.3 Neurological Surgery
    • 5.2.4 Cardiovascular Surgery
    • 5.2.5 Gynecological Surgery
    • 5.2.6 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Baxter International, Inc.
    • 6.1.2 B.Braun Melsungen AG
    • 6.1.3 Becton, Dickinson and Company (C.R. Bard)
    • 6.1.4 Johnson & Johnson
    • 6.1.5 Medtronic, PLC.
    • 6.1.6 MAQUET Holding B.V. & Co. Kg. (Getinge Group)
    • 6.1.7 Cohera Medical Inc.
    • 6.1.8 Integra Lifesciences Holdings Corporation
    • 6.1.9 Commonwealth Serum Laboratories (CSL)
    • 6.1.10 Hemostasis, LLC
    • 6.1.11 CryoLife, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS